Brief: Active Biotech Q3 Loss After Tax At SEK 11.2 Mln
Nov 4 (Reuters) - Active Biotech AB publ ACTI.ST :
* REG-ACTIVE BIOTECH INTERIM REPORT JANUARY - SEPTEMBER 2021
* JULY-SEPT OPERATING LOSS AT SEK 11.3 MILLION VERSUS LOSS
SEK
8.3 MILLION YEAR AGO
* JULY-SEPT LOSS AFTER TAX AT SEK 11.2 MILLION VERSUS LOSS
SEK 8.2
MILLION YEAR AGO
Source text for Eikon: ID:nGNX7vDnHL
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million